Emergency use authorization (EUA) for a traditional herbal formula for treating COVID-19 has been extended until June next year, Minister of Health and Welfare Hsueh Jui-yuan (薛瑞元) said yesterday.
The ministry has extended the EUA for Chingguan Yihau (清冠一號), also marketed as Respire Aid and NRICM101, to give pharmaceutical companies time to complete clinical trials and obtain a drug permit before the authorization expires, Hsueh said.
Hsueh made the remarks at the Taipei Traditional Chinese Medicine International Forum, hosted by the National Union of Chinese Medical Doctors’ Association, where Vice President William Lai (賴清德) said he had taken Chingguan Yihau when he contracted COVID-19.
Photo: Wu Liang-yi , Taipei Times
Lai said that he was not eligible for antiviral drugs, but felt that his respiratory symptoms were greatly relieved by taking the herbal medicine.
More than 1.5 million people have taken Chingguan Yihau for COVID-19 and many still take herbal medicines to relieve their symptoms after an acute infection, association chairman Chan Yung-chao (詹永兆) said.
The number of estimated Chinese herbal medicine users has increased by 40 percent to about 8.15 million people in 2021, he said.
Hsueh said that traditional herbal medicines would be included in the ministry’s drug shortage reporting system as early as next month.
The Pharmaceutical Affairs Act (藥事法) requires pharmaceutical firms to report shortages of drugs to the Food and Drug Administration, but as drug shortage reports are now being reviewed by the ministry, it would include traditional herbal medicines in the system, he said.
The supply of herbal medicine ingredients has been affected by global political and economic events, so Taiwan must re-evaluate the situation and, hopefully, establish a self-sufficient supply chain through cross-ministerial cooperation or with New Southbound Policy countries, he said.
Separately, the Central Epidemic Command Center (CECC) yesterday reported 8,869 new local COVID-19 cases, 12.1 percent fewer than on Sunday last week.
It also reported 224 imported cases and 39 deaths.
Centers for Disease Control (CDC) Deputy Director-General Philip Lo (羅一鈞), who is also the CECC’s spokesman, said that as daily local caseloads have remained at a low level, the next phase of easing the mask mandate for healthcare facilities and at public transportation venues is expected to be discussed in the middle of next month.
Regarding whether more people might report infections this week to receive COVID-19 insurance compensation before it becomes invalid, as mild cases would no longer be required to be reported or enter quarantine from Monday next week, Lo said he expected some slight fluctuations.
However, as no new subvariants of SARS-CoV-2 have been reported recently, daily case counts are not expected to increase by much, he added.
ANOTHER EMERGES: The CWA yesterday said this year’s fourth storm of the typhoon season had formed in the South China Sea, but was not expected to affect Taiwan Tropical Storm Gaemi has intensified slightly as it heads toward Taiwan, where it is expected to affect the country in the coming days, the Central Weather Administration (CWA) said yesterday. As of 8am yesterday, the 120km-radius storm was 800km southeast of Oluanpi (鵝鑾鼻), Taiwan’s southernmost tip, moving at 9kph northwest, the agency said. A sea warning for Gaemi could be issued tonight at the earliest, it said, adding that the storm is projected to be closest to Taiwan on Wednesday or Thursday. Gaemi’s potential effect on Taiwan remains unclear, as that would depend on its direction, radius and intensity, forecasters said. Former Weather Forecast
As COVID-19 cases in Japan have been increasing for 10 consecutive weeks, people should get vaccinated before visiting the nation, the Centers for Disease Control (CDC) said. The centers reported 773 hospitalizations and 124 deaths related to COVID-19 in Taiwan last week. CDC Epidemic Intelligence Center Director Guo Hung-wei (郭宏偉) on Tuesday said the number of weekly COVID-19 cases reported in Japan has been increasing since mid-May and surpassed 55,000 cases from July 8 to July 14. The average number of COVID-19 patients at Japan’s healthcare facilities that week was also 1.39 times that of the week before and KP.3 is the dominant
The Chinese Communist Party’s (CCP) working group for Taiwan-related policies is likely to be upgraded to a committee-level body, a report commissioned by the Mainland Affairs Council (MAC) said. As Chinese President Xi Jinping (習近平) is increasingly likely to upgrade the CCP’s Central Leading Group for Taiwan Affairs, Taiwanese authorities should prepare by researching Xi and the CCP, the report said. At the third plenary session of the 20th Central Committee of the CCP, which ended on Thursday last week, the party set a target of 2029 for the completion of some tasks, meaning that Xi is likely preparing to
US-CHINA TRADE DISPUTE: Despite Beijing’s offer of preferential treatment, the lure of China has dimmed as Taiwanese and international investors move out Japan and the US have become the favored destinations for Taiwanese graduates as China’s attraction has waned over the years, the Ministry of Labor said. According to the ministry’s latest income and employment advisory published this month, 3,215 Taiwanese university graduates from the class of 2020 went to Japan, surpassing for the first time the 2,881 graduates who went to China. A total of 2,300 graduates from the class of 2021 went to the US, compared with the 2,262 who went to China, the document showed. The trend continued for the class of 2023, of whom 1,460 went to Japan, 1,334 went to